Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats.
The effects of soybean-derived phospholipid, PIPS NAGASE(TM) (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.